Rebecca Pogue

Title: The Innovative Contributions of Rebecca Pogue

Introduction

Rebecca Pogue is a notable inventor based in Morrisville, NC (US). She has made significant contributions to the field of immunology through her innovative research and development of dendritic cell compositions. Her work has implications for vaccine preparation and T cell stimulation, showcasing her commitment to advancing medical science.

Latest Patents

Rebecca Pogue holds a patent for "Dendritic cell compositions and methods." This patent describes methods for producing dendritic cells from monocytes that have been incubated at a temperature of 1°C to 34°C for a period of approximately 6 to 96 hours after isolation from a subject. The mature dendritic cells produced using her methods exhibit increased levels of CD80, CD83, CD86, MHC class I, and MHC class II molecules compared to those prepared from monocytes that were not subjected to the specified incubation conditions. This innovation is particularly useful for vaccine development and enhancing T cell responses.

Career Highlights

Rebecca Pogue is currently associated with Argos Therapeutics, Inc., where she continues to apply her expertise in immunology. Her work has led to advancements in the understanding and application of dendritic cells in therapeutic settings. With a patent portfolio that includes 1 patent, she has established herself as a key figure in her field.

Collaborations

Rebecca has collaborated with talented professionals such as Tamara Tatroe Monesmith and Irina Tcherepanova. These collaborations have further enriched her research and contributed to the success of her projects.

Conclusion

Rebecca Pogue's innovative work in dendritic cell research exemplifies her dedication to advancing medical science. Her contributions have the potential to significantly impact vaccine development and immunotherapy.